The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm | Synapse

⌘+K

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Venetoclax plus azacitidine in younger adults with acute myeloid leukemia beyond historical comparisons. Comment on: "Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy"Haematologica · Thu,
2Effects of secondary factor VIII prophylaxis on joint and bone health in a hemophilia A mouse modelHaematologica · Thu,
3Response to Comment on: “Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications”Haematologica · Thu,
4Hyperinflammatory differentiation syndrome with hemophagocytic lymphohistiocytosis-like features following menin inhibition in acute myeloid leukemiaHaematologica · Thu,
5Cord blood-derived natural killer cells engineered with a novel, highaffinity chimeric antigen receptor can eliminate acute myeloid leukemia cells with minimal C-type lectin-like molecule-1 expressionHaematologica · Thu,

More from Haematologica